Dr. Martens plc (LON:DOCS - Get Free Report) insider Giles Wilson acquired 32,640 shares of the firm's stock in a transaction dated Tuesday, March 25th. The stock was bought at an average price of GBX 54 ($0.70) per share, for a total transaction of £17,625.60 ($22,813.36).
Giles Wilson also recently made the following trade(s):
- On Tuesday, March 11th, Giles Wilson purchased 269 shares of Dr. Martens stock. The stock was acquired at an average cost of GBX 56 ($0.72) per share, with a total value of £150.64 ($194.98).
- On Tuesday, February 11th, Giles Wilson acquired 207 shares of Dr. Martens stock. The shares were bought at an average cost of GBX 73 ($0.94) per share, for a total transaction of £151.11 ($195.59).
- On Monday, January 13th, Giles Wilson purchased 222 shares of Dr. Martens stock. The shares were bought at an average price of GBX 68 ($0.88) per share, for a total transaction of £150.96 ($195.39).
Dr. Martens Stock Down 1.7 %
Shares of Dr. Martens stock traded down GBX 0.90 ($0.01) on Friday, reaching GBX 52 ($0.67). 848,501 shares of the company were exchanged, compared to its average volume of 2,764,031. The stock's 50 day moving average price is GBX 64.61 and its 200-day moving average price is GBX 63.43. The company has a market cap of £504.80 million, a P/E ratio of 7.37, a price-to-earnings-growth ratio of 6.40 and a beta of 0.11. Dr. Martens plc has a 1-year low of GBX 49.32 ($0.64) and a 1-year high of GBX 99.40 ($1.29). The company has a debt-to-equity ratio of 127.27, a current ratio of 2.85 and a quick ratio of 1.13.
Dr. Martens Cuts Dividend
The firm also recently declared a dividend, which will be paid on Tuesday, April 8th. Shareholders of record on Thursday, March 6th will be paid a GBX 0.85 ($0.01) dividend. This represents a yield of 1.47%. The ex-dividend date of this dividend is Thursday, March 6th. Dr. Martens's dividend payout ratio is presently 42.53%.
Dr. Martens Company Profile
(
Get Free Report)
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.
The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.
Featured Articles

Before you consider Dr. Martens, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dr. Martens wasn't on the list.
While Dr. Martens currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.